Anna Kazansky

Texas Heart Institute Positions

Publications

Bakthavatsalam, D., Craft, J. W., Kazansky, A. et al. (2020). Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk. Front Immunol 11, 575085. https://doi.org/10.3389/fimmu.2020.575085.
Xie, X., Bartholomeusz, C., Ahmed, A. A. et al. (2013). Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP. Mol Cancer Ther 12, 1099–1111. https://doi.org/10.1158/1535-7163.MCT-12-0737.
Torikoshi, Y., Gohda, K., Davis, M. L. et al. (2013). Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient. J Cancer 4, 697–702. https://doi.org/10.7150/jca.6248.
Bartholomeusz, C., Oishi, T., Saso, H. et al. (2012). MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther 11, 360–369. https://doi.org/10.1158/1535-7163.MCT-11-0400.
Bartholomeusz, C., Gonzalez-Angulo, A. M., Kazansky, A. et al. (2010). PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin Cancer Res 16, 1802–1811. https://doi.org/10.1158/1078-0432.CCR-09-1456.
Bartholomeusz, C., Rosen, D., Wei, C. et al. (2008). PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res 68, 9302–9310. https://doi.org/10.1158/0008-5472.CAN-08-2592.
Rosen, J. M., Zahnow, C., Kazansky, A. et al. (1998). Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem Soc Symp 63, 101–113
Raught, B., Khursheed, B., Kazansky, A. et al. (1994). YY1 represses beta-casein gene expression by preventing the formation of a lactation-associated complex. Mol Cell Biol 14, 1752–1763